H.I.G. Capital, L.L.C., a global private equity investment firm, announced the sale of Vantage Specialty Chemicals to The Jordan Company, a private equity firm with offices in New York, NY, Chicago, IL and Shanghai.
Vantage, headquartered in Chicago, is a uniquely positioned specialty chemicals company focused on naturally derived ingredients for a diverse and growing set of global end markets including personal care, consumer products, industrial and food markets. Vantage converts renewable animal- and vegetable-based raw materials into products that are widely used in a range of specialized applications due to their performance benefits and environmental characteristics.
Vantage was formed by H.I.G. in May 2008 through the acquisition of Croda International’s U.S. oleochemical business (f/k/a Uniqema Americas). Vantage then acquired Lambent Technologies in October 2008 and Lipo Chemicals in July 2010, forming a vertically integrated, natural specialty chemical provider. Today, Vantage maintains a global presence in 13 countries with revenues in excess of $500 million annually.
“H.I.G. has been a tremendous partner to Vantage and has been instrumental in helping us establish and execute our growth strategy,” said Julian Steinberg, CEO of Vantage. “In the last three and a half years, we’ve made two sizeable acquisitions, expanded our global reach, invested in new technologies, and made sizeable capital investments to increase capacity at both of our manufacturing facilities.”
“We have been very fortunate to be able to partner with the executive team at Vantage. They have successfully executed on a number of strategic initiatives and significantly grown the business organically, positioning the Company very well for the future,” commented Rick Rosen, an executive managing director of H.I.G. Capital. “Vantage has been an extremely successful investment for us and our investors. We look forward to watching the company’s continued success in the future.”